Journals / Toraks Dergisi / 2006 / Cilt: 7 - Sayı: 1

Evaluation of the results of lung function tests and COPD risk factors in COPD tent

KOAH çadırında ölçülen SFT sonuçları ve KOAH risk faktörlerinin değerlendirilmesi

Pages
23–28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, FEF25-75 value decreased before the ratio of FEV1/FVC in cases who were above 40 year old and smoker.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:COPD day was made in 2003, November 19 which was organized by Global Initiation (GOLD) all around the world to increase the conciousness about COPD.
📊
Key Findings & Data:In Izmir, spirometry tests were performed to persons who applied to tent and cases older than 40 were questionnaired for risk factors of COPD and about the former diagnosis of COPD.
💡
Conclusion & Impact:In conclusion, FEF25-75 value decreased before the ratio of FEV1/FVC in cases who were above 40 year old and smoker.
🔬Design:Survey & Empirical Study
📍Scope:2003 Verileri
⚙️Variables:Zorlu soluk verme hacmi · Risk faktörleri · Akciğer hastalığı

Abstract

COPD day was made in 2003, November 19 which was organized by Global Initiation (GOLD) all around the world to increase the conciousness about COPD. In Izmir, spirometry tests were performed to persons who applied to tent and cases older than 40 were questionnaired for risk factors of COPD and about the former diagnosis of COPD. Of 361 cases; 97 were female, 264 were male and mean age was 48.00±10.15. 263 cases were ex-smokers or current smokers. Dried cow dung exposition was present in 14 cases. 31 cases had occupational risk for COPD. 13 cases had diagnosis of COPD formerly. All of the cases who had diagnosis of COPD were male, smoker and ratio of FEV1/FVC lower than 70% and the mean values of age and pack-year were significantly higher. 7.8% of all cases had FEV1/FVC ratio less than 70% and 23 of them had FEV1 less than 80%. FEF25-75 was found less than 65% in 73 cases. There was a reverse relation between the age and the values of FEV1, FEV1/FVC and FEF25-75. Among the smokers, FEV1/FVC ratio was low in 9.7%, FEF25-75 was low in 24.4%. Only 21 cases of 58 cases who had lower FEF25-75 value had FEV1/FVC<70%. Mean values of FEV1, FEV1/FVC and FEF25-75 were lower in smokers than non-smokers. In conclusion, FEF25-75 value decreased before the ratio of FEV1/FVC in cases who were above 40 year old and smoker. We thought, this is more valuable in the early diagnosis of COPD.

Özet

Küresel Girişim (GOLD) grubu tarafından tüm dünyada KOAH bilincini artırmak amacıyla organize edilen “Dünya KOAH Günü” 19 Kasım 2003 tarihinde yapıldı. Ülkemizdeki etkinlikler çerçevesinde İzmir’de kurulan çadıra başvuran kişilere solunum fonksiyon testi yapıldı. Olgular, KOAH risk faktörleri ve daha önce KOAH tanısı yönünden sorgulandı. 40 yaş altında olanlar çalışma dışı bırakıldı. Değerlendirmeye alınan 361 kişinin 97’si kadın, 264’ü erkek olup yaş ortalaması 48.00±10.15 idi. 263 kişi 10-100 paket/yıl sigara içmiş veya içmekte idi. 14 olguda tezek maruziyeti saptandı. 31 kişinin mesleği, KOAH yönünden riskli bulundu. 13 olgu daha önce KOAH tanısı almıştı. KOAH tanısı olanların tümü erkek, sigara içen ve FEV1/FVC oranı %70’in altında idi. Bu olguların yaş ve sigara ortalama değerleri KOAH tanısı olmayanlardan daha yüksekti. Tüm olguların %7.8’inde FEV1/FVC %70’in, bunların da 23 ünde FEV1 %80’in altında idi. 73 olguda FEF25-75, %65’in altında bulundu. Yaş ile FEV1, FEV1/FVC ve FEF25-75 arasında ters korelasyon saptandı. Sigara içenlerin %9.7’sinde FEV1/FVC, %24.4’ünde FEF25-75 düşüktü. FEV1/FVC ve FEF25-75 arasında anlamlı ilişki bulunan bu grupta FEF25-75’i düşük olan 58 kişinin sadece 21’inde FEV1/FVC oranı düşüktü. Ayrıca sigara içenlerde FEV1, FEV1/FVC ve FEF25-75 ortalama değerleri içmeyenlerden daha düşüktü. Sonuçta sigara içen 40 yaş üstü kişilerde FEF25-75’in, FEV1/FVC’den daha önce düştüğünü ve bunun KOAH’ın erken tanısı için daha değerli olduğunu düşündük.

🔖

Cite This Article

DEMİR, A., BÜYÜKŞİRİN, M., POLAT, G., KÖMÜRCÜOĞLU, B., TEKGÜL, S., DEMİRCİ, F., KATGI, N., USALAN, A., EREN, A., KÖSE, T., GÜÇLÜ, S. Z., ERDİNÇ, E. (2006). Evaluation of the results of lung function tests and COPD risk factors in COPD tent. Toraks Dergisi, Cilt: 7 - Sayı: 1, 23–28. https://ajindex.com/articles/368159

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease, World Health Organisation, National Heart, Lung and Blood Institute; 2004:1
  2. KOAH Çalışma Grubu. Toraks Derneği Kronik Obstruktif Akciğer Hastalığı Tanı ve Tedavi Rehberi, Toraks Dergisi 2000;1(Ek 2)
  3. Ziedalski TM, Sankaranarayanan V, Chitkara RK. Advances in the management of chronic obstructive pulmonary disease. Expert Opin Pharmacother 2003;4:1063-82
  4. Mannino DM. Chronic obstructive pulmonary disease:definition and epidemiology. Respir Care 2003;48:1185-91; discussion 1191-3
  5. Weiss ST, DeMeo DL, Postma DS. COPD: problems in diagnosis and measurement. Eur Respir J 2003;41(Suppl):4s-12s
  6. Erdinç M. Küçük hava yolu hastalığının tanısında akciğer fonksiyon testlerinin yeri. Solunum 2000;2:148-56
  7. Warren MG. Pulmonary function testing. In: Murray DJ, Nadel J; eds. Textbook of respiratory medicine. 3rd ed. Philadelphia: WB Saunders Company; 2000:781-871
  8. Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med 2004;10:98-103
  9. Jaen Diaz JI, de Castro Mesa C, Gontan Garcia-Salamanca MJ, Lopez de Castro F. Prevalance of chronic obstructive pulmonary disease and risk factors in smokers and ex-smokers. Arch Bronconeumol 2003;39:554-8
  10. Calverley PM, Walker P. Chronic obstructive pulmonary disease. Lancet 2003;362:1053-61
  11. Golshan M, Faghihi M, Marandi MM. Indoor women jobs and pulmonary risks in rural areas of Isfahan, Iran, 2000. Respir Med 2002;96:382-8
  12. Ozbay B, Uzun K, Arslan H, Zehir I. Functional and radiological impairment in women highly exposed to indoor biomass fuels. Respirology 2001;6:255-8
  13. Kiraz K, Kart L, Demir R et al. Chronic pulmonary disease in rural women exposed to biomass fumes. Clin Invest Med 2003;26:243-8
  14. Grippi MA, Metzger LF, Sacks AV, Fishman AP. Pulmonary function testing. In: Fishman AP; ed. Fishman’s pulmonary diseases and disorders. 3rd ed. Philadelphia: Mc Graw-Hill Book Company; 1998:532-74
  15. Nunn JF. Applied respiratory physiology. 2nd edition. Butter Worths 1977;63-138
  16. Ruppel G. Manual of pulmonary function testing. St Louis, Mosby; 1991
  17. Quanjer Ph.H, Tammeling GJ, Cotes JE et al. Lung volumes and forced ventilatory flows. Eur Respir J 1993;16(Suppl):5-40
  18. ATS Statement: Standardization of spirometry-1994 update. Am J Respir Crit Care Med 1995;152:1107-36. 19